Related Experiment Video
Updated: Jan 23, 2026

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Versatile electrostatically assembled polymeric siRNA nanovectors: Can they overcome the limits of siRNA tumor
S Ben Djemaa1, E Munnier1, I Chourpa1
1Université de Tours, EA6295 Nanomédicaments et Nanosondes, 31 Avenue Monge, 37200 Tours, France.
Abstract:
The application of small interfering RNA (siRNA) cancer therapeutics is limited by several extra- and intracellular barriers including the presence of ribonucleases that degrade siRNA, the premature clearance, the impermeability of the cell membrane, or the difficulty to escape endo-lysosomal degradation. Therefore, several delivery systems have emerged to overcome these limitations and to successfully deliver siRNA to the tumor site. This review is focused on polymer-based siRNA nanovectors which exploit the negative charge of siRNA, representing a major challenge for siRNA delivery, to their advantage by loading siRNA via electrostatic assembly. These nanovectors are easy to prepare and to adapt for an optimal gene silencing efficiency. The ability of electrostatically assembled polymeric siRNA nanovectors (EPSN) to improve the half-life of siRNA, to favor the specificity of the delivery and the accumulation in tumor and to enhance the cellular uptake and endosomal escape for an efficient siRNA delivery will be discussed. Finally, the influence of the versatility of the structure of these nanovectors on the protein down-regulation will be evaluated.
Insights
Polymer-based nanovectors efficiently deliver small interfering RNA (siRNA) cancer therapeutics by overcoming biological barriers. These electrostatically assembled polymeric siRNA nanovectors (EPSN) enhance tumor accumulation and gene silencing efficacy.
Area of Science:
- Biotechnology
- Nanomedicine
- Cancer Therapeutics
Background:
- Small interfering RNA (siRNA) cancer therapies face delivery challenges like degradation and poor cellular uptake.
- Existing delivery systems struggle to overcome extra- and intracellular barriers effectively.
Purpose of the Study:
- To review polymer-based siRNA nanovectors for cancer therapy.
- To highlight the advantages of electrostatically assembled polymeric siRNA nanovectors (EPSN) in overcoming siRNA delivery limitations.
Main Methods:
- Focus on polymer-based nanovectors utilizing electrostatic assembly for siRNA loading.
- Discussion of nanovector properties influencing siRNA half-life, tumor targeting, and cellular delivery.
- Evaluation of structural versatility's impact on protein down-regulation.
Main Results:
- EPSN offer a promising strategy to protect siRNA from degradation and premature clearance.
- These nanovectors enhance tumor-specific delivery, cellular uptake, and endosomal escape.
- Nanovector structure versatility correlates with improved gene silencing efficiency.
Conclusions:
- Electrostatically assembled polymeric siRNA nanovectors (EPSN) are effective tools for cancer therapy delivery.
- EPSN overcome key barriers, improving siRNA stability, targeting, and therapeutic outcomes.
- Further research into nanovector structural modifications can optimize gene silencing for cancer treatment.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Small interfering RNAs (siRNA)
Electrostatic Boundary Conditions
The surface integral of an electric field is given by Gauss's law in integral form and is related to...
Limiting Reactant
The Number e as a Limit
Electrostatic Boundary Conditions in Dielectrics
Consider a case where both the mediums across a boundary are two different dielectric materials. Recall that the electric field and electric displacement are proportional and related through the material's permittivity....

